Literature DB >> 565450

L-DOPA reversal of hyperdopaminergic behaviour.

C Ezrin-Waters, P Seeman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 565450     DOI： 10.1016/0024-3205(78)90271-0

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  11 in total

1.  Sustained levodopa therapy in tardive dyskinesia.

Authors:  R J Hardie; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

2.  Reduction of dopaminergic supersensitivity by a single dose of amphetamine.

Authors:  J L Haracz; L F Tseng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

3.  Treatment of infertility with levodopa.

Authors:  F Lechin; B Van der Dijs
Journal:  Br Med J       Date:  1980-02-16

4.  Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.

Authors:  A V Christensen; I M Nielsen
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

5.  Left hemisphere hyperactivity in schizophrenia: abnormality inherent to psychosis or neuroleptic side-effects?

Authors:  R Tomer; M Mintz; M S Myslobodsky
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Levodopa and receptor sensitivity modification in tardive dyskinesia.

Authors:  D E Casey; J Gerlach; N Bjørndal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.

Authors:  N Turjanski; W Fernandez; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

8.  The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.

Authors:  M Globus; J Bannet; B Lerer; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.

Authors:  M Guttman; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes.

Authors:  S Hjorth; D Clark; K Svensson; A Carlsson; O Thorberg
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.